Transcell has been able to create a cell-based products/platforms portfolio through a unique and proprietary technology to obtain application-specific yield advancing the cell based studies for researchers
- We are proud to introduce our nouvelle platforms as Human Surrogate In Vitro Systems (HuSu) for testing Safety & Efficacy related endpoints to do with Pharmaceutical Candidates. To know more please visit transtoxbio
- HEMATO for practising Hemato-oncologists in India. To know more visit Hemato-global